Several cancer-related signaling pathways are reportedly activated by TRIM14, such as the AKT pathway in osteosarcoma [34], the NF-κB pathway in tongue squamous cell carcinoma [35], and the Wnt/β-catenin pathway in glioma [36]. This evidence concerns the gene NFKB1 and cancer.